Clinical Trial

Optimal Strategy to Correct Stent underexpAnsion in Resistant Lesions

Study acronym: OSCAR
Recruiting
View on ClinicalTrials.gov →
Summary
Percutaneous coronary intervention (PCI) for in-stent restenosis (ISR) accounts for 5-10% of PCI. ISR may be linked to mechanical complications mainly under-expansion (UE), neointimal hyperplasia and/or neoatherosclerosis. International guidelines recommends non-compliant and very-high-pressure balloons, which lead to sub-optimal angiographic and clinical results. Recently, observational studies have suggested the feasibility and safety of intravascular lithotripsy (IVL) in UE treatment. There are no prospective randomised controlled studies comparing intravascular lithotripsy with balloons in ISR with UE.
Trial Details
NCT Number NCT07316504
Lead Sponsor University Hospital, Clermont-Ferrand
Conditions Coronary Angioplasty, Restenosis, Lithotripsy, Restenosis of Coronary Artery Stent, Angioplasty, Transluminal, Percutaneous Coronary, Percutaneous Coronary Intervention (PCI), OCT Angiography, Optical Coherence Tomography (OCT) +5 more
Enrollment 80 participants
Start Date 2025-10-22
Primary Completion 2028-09 (estimated)
Study Completion 2031-09 (estimated)
Updated on ClinicalTrials.gov 2026-01-05